Paul W. Hoelscher, EVP, CFO at Horizon Therapeutics Public Ltd Co (HZNP), sold 1,359 shares at $28.00 ($38K) on 2019-08-30, disclosed to the SEC on 2019-09-04.
Scheduled sale ($38k) by EVP, CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HZNP | SELL | 2022-03-25 | $5.7M | — | Filing → |
| HZNP | SELL | 2021-12-30 | $943K | — | Filing → |
| HZNP | SELL | 2021-05-14 | $18.5M | — | Filing → |